Full text is available at the source.
Mechanism of cross‐resistance to cisplatin in a mitomycin C‐resistant human bladder cancer cell line
How resistance to mitomycin C may cause resistance to cisplatin in human bladder cancer cells
AI simplified
Page updated
Abstract
The J82/MMC cell line displayed 2- to 3-fold cross-resistance to cisplatin compared to parental J82/WT cells.
- Cross-resistance to cisplatin in J82/MMC cells is independent of reduced platinum accumulation.
- J82/MMC cells show approximately a 1.5-fold resistance to cadmium chloride, indicating increased metallothionein content.
- Northern blot analysis revealed a 2.7-fold increase in MT-IIA mRNA levels in J82/MMC cells compared to J82/WT.
- Elevated glutathione transferase activity in J82/MMC cells is linked to over-expression of pi-type GST protein.
- GSH depletion enhances cisplatin cytotoxicity more significantly in J82/MMC cells (about 2.1-fold) compared to J82/WT (about 1.6-fold).
AI simplified